Comparison of overall survival between antiviral‐induced viral suppression and inactive phase chronic hepatitis B patients

Summary Nucleot(s)ide analogues ( NA s) reduce the risk of hepatocellular carcinoma ( HCC ) in chronic hepatitis B ( CHB ) patients. However, the risk of HCC is reportedly higher for NA ‐treated patients than for patients in the inactive CHB phase. This study aimed to compare the long‐term outcomes of CHB patients with NA ‐induced viral suppression and those of patients with inactive CHB . This retrospective study involved 1118 consecutive CHB...